Stay updated on Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial page.

Latest updates to the Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial page
- Check7 days agoChange DetectedRevision: v3.5.3 has been added and Revision: v3.5.2 removed, updating the study documents version. This reflects an update to the study protocol materials rather than changes to trial results or core content.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedRevision tag updated to v3.5.0, replacing the previous v3.4.3 tag. This is a UI/version update with no changes to the page content.SummaryDifference0.1%

- Check57 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 on the page.SummaryDifference0.1%

- Check86 days agoChange DetectedThe page shows a site revision update to v3.4.2 and removal of a prior government-funding status notice (v3.4.1). These changes are maintenance-related and do not alter the displayed study details or outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check93 days agoChange DetectedA site-wide notice about a lapse in government funding has been added, stating information may not be up to date and the NIH Clinical Center is open, with links to cc.nih.gov and opm.gov. The page's revision tag updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

Stay in the know with updates to Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial page.